NiravNShahMD

PubMed

• A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen.
  Karmali, R., Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas Kl...> ;Blood Advances. 2024 Apr 9
• The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitors.
  Fateeha Furqan, Nirav N Shah> ;Clinical Advances in Hematology & Oncology. 2024 Apr 1
• 2 citations
  Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohor...
  Muhammad Bilal Abid, Micah Rubin, Aniko Szabo, Walter Longo, Timothy S Fenske, Cole McCoy, Aaron Lorge, Sameem Abedin, Anita D'Souza, Binod Dhakal, Nirav N Shah, Mehdi...> ;Transplantation and Cellular Therapy. 2024 Mar 1
• Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy ...
  Mohan, M., Szabo, A., Patwari, A., Esselmann, J., Patel, T., Bachu, R., Rein, L., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Skoog, C., Goff, A., Hadidi, S., Rad...> ;Bone Marrow Transplantation. 2024 Feb 15
• Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogen...
  Chhabra, S., Jerkins, J., Monahan, K., Szabo, A., Shah, N., Abedin, S., Runaas, L., Fenske, T., Pasquini, M., Shaw, B., Drobyski, W., Saber, W., D'Souza, A., Dhakal, B...> ;Bone Marrow Transplantation. 2024 Mar 1
• Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell Lymphoma.
  Alexandra Rezazadeh, Julie Pruett, Amy Detzner, Natasha Edwin, Mehdi Hamadani, Nirav N Shah, Timothy S Fenske> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Apr 1
• Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
  Jackson T Bowers, Jacob Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A Spinner, Shuning Li, Marcus R Mess...> ;Blood Advances. 2023 Nov 14
• 1 citations
  Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt's Lymphoma.
  Troy J Kenkel, Maria Hintzke, Nirav N Shah, Hammons, L., Sridhar, N.> ;Medical Sciences. 2023 Oct 12
• 21 citations
  Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
  Anthony R Mato, Jennifer A Woyach, Jennifer R Brown, Paolo Ghia, Krish Patel, Toby A Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S Tam, Nirav N Sh...> ;The New England Journal of Medicine. 2023 Jul 6
• 29 citations
  Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
  Ombrello, A. K., Ombrello, A. K., Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain, Sairah Ahmed, Matthew J Frigault, Joshua A Hill, Micha...> ;Transplantation and Cellular Therapy. 2023 Jul 1
• 10 citations
  Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
  Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B Cohen, Tamara K Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sa...> ;Blood Advances. 2023 Jun 27
• 17 citations
  Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
  Tanya Siddiqi, David G Maloney, Saad S Kenderian, Danielle M Brander, Kathleen Dorritie, Jacob Soumerai, Peter A Riedell, Nirav N Shah, Rajneesh Nath, Bita Fakhri, Deb...> ;Lancet. 2023 Aug 19
• 5 citations
  Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells.
  Barbra J Sasu, Gregory J Opiteck, Suhasni Gopalakrishnan, Vivek Kaimal, Tom Furmanak, David Huang, Angshumala Goswami, Ying He, Jiamin Chen, Anh Nguyen, Arun Balakumar...> ;Molecular Therapy. 2023 Mar 1
• 3 citations
  BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma.
  Toby A Eyre, Nirav N Shah, Martin Dreyling, Wojciech Jurczak, Yucai Wang, Chan Y Cheah, Yuqin Song, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J Andorsky, Han...> ;Future Oncology. 2022 Nov 1
• 10 citations
  Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss.
  Nirav N Shah, Furqan, F.> ;Annual Review of Medicine. 2023 Jan 27
• 2 citations
  Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomes.
  Jennifer M Knight, Edward Hackett, Aniko Szabo, Ruizhe Wu, Garrett Sauber, Bryon Johnson, Rachel N Cusatis, Elizabeth Aughey, Steve W Cole, Cecilia J Hillard, Nirav N ...> ;Haematologica. 2023 Feb 1
• Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transp...
  Saurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, Fenlu Zhu, Xiaoying Tang, Mei-Jie Zhang, Robert Thompson, Sameem Abedin, Anita D'Souza, Binod Dhakal, William R D...> ;Transplantation and Cellular Therapy. 2022 Oct 1
• 5 citations
  Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells.
  Joanna C Zurko, Timothy S Fenske, Bryon D Johnson, Daniel Bucklan, Aniko Szabo, Huiqing Xu, Katherine Chaney, Mehdi Hamadani, Parameswaran Hari, Nirav N Shah> ;American Journal of Hematology. 2022 Dec 1
• 11 citations
  Perspective: An International Fludarabine Shortage: Supply Chain Issues Impacting Transplantation and Immune Effector Cell Therapy Delivery.
  Richard T Maziarz, Amber Diaz, David B Miklos, Nirav N Shah> ;Transplantation and Cellular Therapy. 2022 Nov 1
• 5 citations
  Bispecific CAR T-cells for B-cell Malignancies.
  Nirav N Shah, Furqan, F.> ;Expert Opinion on Biological Therapy. 2022 Aug 1
• 7 citations
  Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies.
  Joanna C Zurko, Huiqing Xu, Katherine Chaney, Dina Schneider, Aniko Szabo, Parameswaran Hari, Bryon D Johnson, Nirav N Shah> ;Cytotherapy. 2022 Aug 1
• 10 citations
  Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome.
  Joanna C Zurko, Bryon D Johnson, Emilie Aschenbrenner, Timothy S Fenske, Mehdi Hamadani, Parameswaran Hari, Nirav N Shah> ;JAMA Oncology. 2022 May 1
• 33 citations
  Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients.
  Muhammad Bilal Abid, Micah Rubin, Nathan Ledeboer, Aniko Szabo, Walter Longo, Meera Mohan, Nirav N Shah, Timothy S Fenske, Sameem Abedin, Lyndsey Runaas, Anita D'Souza...> ;Cancer Cell. 2022 Apr 11
• 1 citations
  Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol.
  Alexander K Johnson, Ellen L Lorimer, Aniko Szabo, Ruizhe Wu, Nirav N Shah, Anita D'Souza, Saurabh Chhabra, Mehdi Hamadani, Binod Dhakal, Parameswaran Hari, Sridhar Ra...> ;The Yale Journal of Biology and Medicine. 2022 Mar 1
• Hemophagocytosis in cerebrospinal fluid after CAR T-cell therapy.
  Nirav N Shah, Alexandra M Harrington> ;Blood. 2022 Feb 17
• Join now to see all

Lectures

• Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
• Fresh Versus Cryopreserved/Thawed Bispecific Anti-CD19/CD20 CAR-T Cells for Relapsed, Refractory Non-Hodgkin Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019